Literature DB >> 10363903

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.

J F Moley1, M K DeBenedetti.   

Abstract

OBJECTIVE: To establish the frequency, pattern and location of cervical lymph node metastases from palpable medullary thyroid carcinoma (MTC). Recommendations are made regarding the extent of surgery for this tumor. SUMMARY BACKGROUND DATA: Medullary thyroid carcinoma is a tumor of neuroendocrine origin that does not concentrate iodine. Surgical extirpation of the thyroid tumor and cervical node metastases is the only potentially curative therapeutic option. Patterns of node metastases in the neck and guidelines for the extent of dissection for palpable MTC are not well established.
METHODS: Seventy-three patients underwent thyroidectomy for palpable MTC with immediate or delayed central and bilateral functional neck dissections. The number and location of lymph node metastases in the central (levels VI and VII) and bilateral (levels II to V) nodal groups were noted and were correlated with the size and location of the primary thyroid tumor. Intraoperative assessment of nodal status by palpation and inspection by the surgeon was correlated with results of histologic examination.
RESULTS: Patients with unilateral intrathyroid tumors had lymph node metastases in 81% of central node dissections, 81% of ipsilateral functional (levels II to V) dissections, and 44% of contralateral functional (levels II to V) dissections. In patients with bilateral intrathyroid tumors, nodal metastases were present in 78% of central node dissections, 71% of functional (levels II to V) node dissections ipsilateral to the largest intrathyroid tumor, and 49% of functional (levels II to V) node dissections contralateral to the largest thyroid tumor. The sensitivity of the surgeon's intraoperative assessment for nodal metastases was 64%, and the specificity was 71%.
CONCLUSION: In this series, >75% of patients with palpable MTC had associated nodal metastases, which often were not apparent to the surgeon. Routine central and bilateral functional neck dissections should be considered in all patients with palpable MTC.

Entities:  

Mesh:

Year:  1999        PMID: 10363903      PMCID: PMC1420836          DOI: 10.1097/00000658-199906000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study.

Authors:  H Scherübl; F Raue; R Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.

Authors:  J A van Heerden; C S Grant; H Gharib; I D Hay; D M Ilstrup
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

3.  Nonfamilial medullary thyroid carcinoma.

Authors:  R L Rossi; B Cady; W A Meissner; M S Wool; C E Sedgwick; J Werber
Journal:  Am J Surg       Date:  1980-04       Impact factor: 2.565

4.  Radioactive iodine in the treatment of medullary carcinoma of the thyroid.

Authors:  M F Saad; J J Guido; N A Samaan
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

5.  Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid.

Authors:  E D Williams; C L Brown; I Doniach
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

6.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Authors:  H Dralle; I Damm; G F Scheumann; J Kotzerke; E Kupsch; H Geerlings; R Pichlmayr
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 7.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

8.  Medullary thyroid carcinoma: importance of serial serum calcitonin measurement.

Authors:  A V Stepanas; N A Samaan; C S Hill; R C Hickey
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

9.  Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Authors:  S A Wells; D D Chi; K Toshima; L P Dehner; C M Coffin; S B Dowton; J L Ivanovich; M K DeBenedetti; W G Dilley; J F Moley
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Medullary thyroid carcinoma: prognostic factors and treatment.

Authors:  P Rougier; C Parmentier; A Laplanche; M Lefevre; J P Travagli; B Caillou; M Schlumberger; J Lacour; M Tubiana
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-02       Impact factor: 7.038

View more
  70 in total

Review 1.  Thyroid cancer surgery.

Authors:  R Udelsman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  Occult primary medullary thyroid carcinoma presenting with pituitary and parotid metastases: case report and review of the literature.

Authors:  Andrea Conway; Andres Wiernik; Ajay Rawal; Cornelius Lam; Hector Mesa
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

3.  Adjuvant external beam radiation for medullary thyroid carcinoma.

Authors:  Steve R Martinez; Shannon H Beal; Allen Chen; Steven L Chen; Philip D Schneider
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

4.  Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review.

Authors:  Darren K Patten; Rashpal Flora; Neil Tolley; Fausto Palazzo
Journal:  Int J Surg Case Rep       Date:  2011-11-22

Review 5.  Medullary thyroid cancer: monitoring and therapy.

Authors:  Douglas W Ball
Journal:  Endocrinol Metab Clin North Am       Date:  2007-09       Impact factor: 4.741

Review 6.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

7.  Chronic diarrhoea--all in the bowel?

Authors:  S Gupta; C J Tibbs; M J G Farthing; R C G Pollok
Journal:  J R Soc Med       Date:  2007-08       Impact factor: 5.344

8.  Results of Surgical Therapy in Patients with Medullary Thyroid Carcinoma.

Authors:  Mihaela Vlad; Ioana Zosin; Bogdan Timar; Fulger Lazar; Adrian Vlad; Romulus Timar; Marioara Cornianu
Journal:  Indian J Surg       Date:  2015-11-12       Impact factor: 0.656

Review 9.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 10.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.